PPARγ agonists can inhibit these effects of ANG II by suppression of the ANG II-induced signaling pathway, which suggests that PPARγ agonists have beneficial effects against atherosclerosis and restenosis [39-41]. This evidence concerns the gene PPARG and atherosclerosis.